Developing trustworthy recommendations as part of an urgent response (1-2 weeks): a GRADE concept paper.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
01 2021
Historique:
received: 06 06 2020
revised: 27 07 2020
accepted: 01 09 2020
pubmed: 4 10 2020
medline: 7 9 2021
entrez: 3 10 2020
Statut: ppublish

Résumé

The aim of this study is to propose an approach for developing trustworthy recommendations as part of urgent responses (1-2 week) in the clinical, public health, and health systems fields. We conducted a review of the literature, outlined a draft approach, refined the concept through iterative discussions, a workshop by the Grading of Recommendations Assessment, Development and Evaluation Rapid Guidelines project group, and obtained feedback from the larger Grading of Recommendations Assessment, Development and Evaluation working group. A request for developing recommendations within 2 week is the usual trigger for an urgent response. Although the approach builds on the general principles of trustworthy guideline development, we highlight the following steps: (1) assess the level of urgency; (2) assess feasibility; (3) set up the organizational logistics; (4) specify the question(s); (5) collect the information needed; (6) assess the adequacy of identified information; (7) develop the recommendations using one of the 4 potential approaches: adopt existing recommendations, adapt existing recommendations, develop new recommendations using existing adequate systematic review, or develop new recommendations using expert panel input; and (8) consider an updating plan. An urgent response for developing recommendations requires building a cohesive, skilled, and highly motivated multidisciplinary team with the necessary clinical, scientific, and methodological expertise; adapting to shifting needs; complying with the principles of transparency; and properly managing conflicts of interest.

Identifiants

pubmed: 33010401
pii: S0895-4356(20)31123-9
doi: 10.1016/j.jclinepi.2020.09.037
pmc: PMC7526592
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Subventions

Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU13
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU17
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SCAF/15/02
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/13
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

J Clin Epidemiol. 2017 Feb;82:47-60
pubmed: 27591906
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Lancet Infect Dis. 2007 Jan;7(1):21-31
pubmed: 17182341
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
JAMA. 2019 Aug 27;322(8):725-726
pubmed: 31322650
J Clin Epidemiol. 2011 Dec;64(12):1303-10
pubmed: 21802903
Implement Sci. 2014 Jan 02;9:3
pubmed: 24383701
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
BMJ. 2016 Jul 20;354:i3507
pubmed: 27443385
Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
J Clin Epidemiol. 2017 Jan;81:101-110
pubmed: 27713072
Health Res Policy Syst. 2018 Jul 13;16(1):63
pubmed: 30005679
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Curr Med Sci. 2020 Apr;40(2):275-280
pubmed: 32207032
PLoS Med. 2006 Sep;3(9):e343
pubmed: 16968120
Clin Infect Dis. 2020 Apr 27;:
pubmed: 32338708
Emerg Microbes Infect. 2020 Dec;9(1):687-690
pubmed: 32208840
J Clin Epidemiol. 2017 Nov;91:47-53
pubmed: 28911999
Clin Infect Dis. 2020 Jul 28;71(15):740-747
pubmed: 32211844
J Clin Epidemiol. 2016 Jan;69:225-34
pubmed: 26092286
Syst Rev. 2020 Feb 1;9(1):21
pubmed: 32007104
J Clin Epidemiol. 2021 Feb;130:13-22
pubmed: 33068715
Ann Intern Med. 2020 Jul 21;173(2):137-142
pubmed: 32422063
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
Health Qual Life Outcomes. 2017 Sep 21;15(1):183
pubmed: 28934978
Ann Intern Med. 2020 Aug 4;173(3):204-216
pubmed: 32442035
Health Res Policy Syst. 2018 Jul 13;16(1):61
pubmed: 30005712
Gastroenterology. 2020 Aug;159(2):739-758.e4
pubmed: 32247018
Environ Int. 2016 Jul-Aug;92-93:585-9
pubmed: 27126781
N Engl J Med. 2020 Apr 23;382(17):e37
pubmed: 32237671
Health Res Policy Syst. 2018 Jul 13;16(1):62
pubmed: 30005710
Health Res Policy Syst. 2018 May 29;16(1):45
pubmed: 29843743
Implement Sci. 2016 Jul 15;11:93
pubmed: 27417219
BMJ. 2019 Jul 19;366:l4606
pubmed: 31324659

Auteurs

Elie A Akl (EA)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada. Electronic address: ea32@aub.edu.lb.

Rebecca L Morgan (RL)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.

Andrew A Rooney (AA)

National Institute of Environmental Health Science, Durham, NC, USA.

Brandiese Beverly (B)

National Institute of Environmental Health Science, Durham, NC, USA.

Srinivasa Vittal Katikireddi (SV)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow G2 3AX, UK.

Arnav Agarwal (A)

Department of Medicine, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent West, Third Floor, Toronto, ON M5S 3H2, Canada.

Brian S Alper (BS)

Department of Family and Community Medicine, Medical Knowledge Office, EBSCO Information Services, University of Missouri-Columbia School of Medicine, 10 Estes Street, Ipswich, MA 01938, USA.

Carlos Alva-Diaz (C)

Universidad Científica del Sur, Facultad de Ciencias de la Salud, Panamericana, Sur km 19, Villa, Lima, Peru.

Laura Amato (L)

Department of Epidemiology, Lazio Regional Health Services Rome, via Cristoforo Colombo 112, 00147 Rome, Italy.

Mohammed T Ansari (MT)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, Ontario K1G 5Z3, Canada.

Jan Brozek (J)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.

Derek K Chu (DK)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Rm 3V49 McMaster University Medical Centre, Hamilton, ON L8S 4K1, Canada; Department of Medicine, Rm 3V49 McMaster University Medical Centre, Hamilton, ON L8S 4K1, Canada; The Research Institute of St. Joe's Hamilton, Rm 3V49 McMaster University Medical Centre, Hamilton, ON L8S 4K1, Canada.

Philipp Dahm (P)

Department of Urology, Minneapolis VA Healthcare System, Urology Section, University of Minnesota, One Veterans Drive, Minneapolis, MN 55417, USA.

Andrea J Darzi (AJ)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.

Maicon Falavigna (M)

Hospital Moinhos de Vento, Porto Alegre, Brazil.

Gerald Gartlehner (G)

Department for Evidence-based Medicine and Evaluation, RTI International, Danube University, Dr. Karl Dorrekstrasse, Krems Austria, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.

Hector Pardo-Hernandez (H)

Iberoamerican Cochrane Centre, Sant Pau Biomedical Research Institute (IIB Sant Pau), CIBER de Epidemiología y Salud Pública (CIBERESP), Carrer Sant Antoni Maria Claret, 167, Pavelló 18, Planta Baja (Ground Floor), 08025 Barcelona, Spain.

Valerie King (V)

Center for Evidence-based Policy, Oregon Health & Science University, 3030 South Moody Ave., Suite 250, Portland, OR 97201, USA.

Jitka Klugarová (J)

Czech National Centre for Evidence-Based Healthcare and Knowledge Translation, Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

M W Miranda Langendam (MWM)

Amsterdam UMC, University of Amsterdam, Epidemiology and Data Science, Amsterdam Institute of Public Health, Meibergdreef 9, Amsterdam, the Netherlands.

Craig Lockwood (C)

JBI, School of Public Health, University of Adelaide, Level 3/55 King William Road, North Adelaide 5005, Australia.

Manoj Mammen (M)

Department of Medicine, State University of New York at Buffalo, 100 High Street, Buffalo, NY, USA.

Alexander G Mathioudakis (AG)

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, 2nd Floor, Education and Research Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester M23 9LT, UK; The North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, 2nd Floor, Education and Research Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester M23 9LT, UK.

Michael McCaul (M)

Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Teaching Building, Faculty of Medicine and Health Sciences, Francie van Zijl Drive, Bellville, Western Cape, South Africa.

Joerg J Meerpohl (JJ)

Institute for Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Breisacher Strasse 153, 79110 Freiburg, Germany; Cochrane Germany, Cochrane Germany Foundation, Breisacher Strasse 153, 79110 Freiburg, Germany.

Silvia Minozzi (S)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Reem A Mustafa (RA)

Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, MS3002, Kansas City, KS 66160, USA; Department of Health Research Methods, Evidence, and Impact, McMaster University, 3901 Rainbow Blvd, MS3002, Kansas City, KS 66160, USA.

Francesco Nonino (F)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Epidemiologia e Statistica, IRCCS-ISNB, Ospedale Bellaria, Via Altura, 3, 40139 Bologna, Italy.

Thomas Piggott (T)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West 2C Area, Hamilton, Ontario L8S 4K1, Canada.

Amir Qaseem (A)

American College of Physicians, 190 N Independence Mall West, Philadelphia, PA 19087, USA.

John Riva (J)

Department of Family Medicine, Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.

Rachel Rodin (R)

Public Health Agency of Canada, 785 Carling Avenue, Ottawa, Ontario, Canada.

Nigar Sekercioglu (N)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.

Nicole Skoetz (N)

Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Evidence-based Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 15, 50935 Cologne, Germany.

Gregory Traversy (G)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Kris Thayer (K)

U.S. Environmental Protection Agency, Office of Research and Development (ORD, Center for Public Health and Environmental Assessment (CPHEA), Mail Code: B243-01, Building: Bldg B (Room B210I), Research Triangle Park, NC 27711, USA.

Holger Schünemann (H)

Department of Health Research Methods, Evidence, and Impact, McMaster University, McMaster University Medical Centre, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH